← Leaderboards
Amy L Rubinstein
Zygogen, Llc
$1,629,799
Attributed
$1,629,799
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $643.8K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$1,629,799 · 3
By mechanism
R44$1,289,719 · 1
R43$340,080 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationBioassayAntihypercholesterolemic AgentComputer Program /SoftwareComputer System Design /EvaluationDisease /Disorder ModelDrug Discovery /IsolationFluorescent Dye /ProbeHigh Throughput TechnologyLipid MetabolismPharmacokineticsPhospholipase A2Technology /Technique DevelopmentBiomedical AutomationBiotechnologyCardiovascular DisorderHypercholesterolemiaLarvaThin Layer ChromatographyZebrafishAquaculture
Grant awards (4)
Zebrafish Tauopathy Model for Drug Screening and Target Validation$153,320
R43 · FY2006 · AG · contact PI
Zebrafish Lipid Metabolism Assay for Drug Screening$643,750
R44 · FY2005 · DK
Zebrafish Lipid Metabolism Assay for Drug Screening$645,969
R44 · FY2004 · DK
Zebrafish Assay for Cholesterol and Lipid Lowering Drugs$186,760
R43 · FY2003 · DK